178 replies to this topic

[ImmInst]

RegMed sector, waiting to feel the love … in my statement
Proactive Investors USA & Canada - 4 hours ago

The 6 W's: Who, what, where, when, why and what of it. Optimism tempered by caution and sustainability fear. Mid-Day: The NASDAQ is UP +38.13 (+1.28%) to 3028.04 while the Dow is UP +91.65 (+0.7%) to 13209.16.

View the full article

[ImmInst]

RegMed sector polar glasses are shading the view
Proactive Investors USA & Canada - 13 hours ago

RegMed sector polar glasses are shading the view. Fri 3:35 pm by Henry McCusker. The 6 W's: Who, what, where, when, why and what of it… As investor tiptoe through the beach rocks into the weekend - TGIF!

View the full article

[ImmInst]

Equity Briefing: Pluristem partners with prestigious Institute for trial of ...
Reuters - 2 hours ago

A news announcement from Pluristem (NASDAQ:PSTI) indicates that those afflicted with peripheral arterial disease, or PAD, may soon have an alternative to Bristol-Myer Squibb's (NYSE:BMY) troubled anti-clotting drug Plavix, whose drawbacks prompted the ...

View the full article

[ImmInst]

RegMed sector, a hazy day to find my way and take a breather
Proactive Investors USA & Canada - 14 hours ago

The 6 W's: Who, what, where, when, why and what of it … A least I won't get burned by the hot sun reflecting off my monthly statement.

View the full article

[ImmInst]

RegMed sector tallies shallow gains
Proactive Investors USA & Canada - Aug 9, 2012

The 6 W's: Who, what, where, when, why and what of it… Earnings calls, so far … reflect mediocrity in milestones. Mid-Day: The NASDAQ is UP +0.65 (+0.02%) to 3,011.90 while the Dow is DOWN -23.58 (-0.18%) to 13,152.06.

View the full article

[ImmInst]

RegMed sector, what keeps me awake at night?
Proactive Investors USA & Canada - Aug 14, 2012

The 6 W's: Who, what, where, when, why and what of it… Determining who is the sector's tortoise or hare. Mid-Day: The NASDAQ is DOWN -0.80 (-0.03%) to 3,021.72 while the Dow is UP +19.90 (+0.15%) to 13,189.33.

View the full article

[ImmInst]

RegMed sector hugs the flatline
Proactive Investors USA & Canada - Aug 15, 2012

The 6 W's: Who, what, where, when, why and what of it … No volume energy and low interest. Mid-Day: The NASDAQ is UP +13.86 (+0.46%) to 3030.84 while the Dow is also UP +3.21 (+0.02%) to 13175.35.

View the full article

[ImmInst]

Teva Pharma (TEVA) Says NDA for Quartette Tabs Accepted by US FDA
StreetInsider.com (subscription) - Aug 13, 2012

EPS Growth %: +16.4%. Teva Women's Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), today announced that the U.S.

View the full article

[ImmInst]

Biotech Industry Benefiting From Favorable Legislation Introduced in 2012
Marketwire (press release) - 1 hour ago

NEW YORK, NY--(Marketwire - Aug 22, 2012) - Biotechnology stocks continue to be some of the strongest performers in the markets as favorable legislation, such as the FAST and TREAT acts, have helped boost investor optimism within the industry.

View the full article

[ImmInst]

NeoStem (NYSE MKT: NBS) No monetary offering, filings tidy up the books and ...
Proactive Investors USA & Canada - 3 hours ago

Facts versus fiction. Three (3) filing titles: NBS filed a … Post-Effective Amendment No.1 Form S-3 to Registration Statements on Form S-4 on 8/24/12, a Change in Directors and/or Principal Officer and a Mixed Securities Shelf Registration for $150M.

View the full article

[ImmInst]

RegMed sector sentiment melts with thin trading
Proactive Investors USA & Canada - 10 hours ago

The 6 W's: Who, what, where, when, why and what of it. Stock prices slide sideways. Mid-Day: The NASDAQ is UP +11.17 (+0.36%) to 3,080.96 while the Dow is also UP +6.43 (+0.05%) to 13,164.40.

View the full article

[ImmInst]

Repros Says FDA Provided Guidance for Phase 2 Study of Proellex; Novabay ...
Proactive Investors USA & Canada - 1 hour ago

Below is a look at some of the headlines for companies that made news in the healthcare sector on August 27, 2012. Repros Therapeutics (Nasdaq: RPRX) announced the FDA has provided guidance for a Phase 2 study of low dose oral Proellex^® in the ...

View the full article

[ImmInst]

RegMed sector suffers lack of interest in slowest week of the year
Proactive Investors USA & Canada - 1 hour ago

The 6 W's: Who, what, where, when, why and what of it. Another no to low volume day, what do you expect? Mid-Day: The NASDAQ is UP +1.77 (+0.25%) to 3,080.96 while the Dow is also UP +10.96 (+0.08%) to 13,131.63.

View the full article

[ImmInst]

RegMed sector's waiting for Godot, any good news or was it Bernanke?
Proactive Investors USA & Canada - 1 hour ago

The 6 W's: Who, what, where, when, why and what of it. Sitting in a thin volume seat, waiting for what again? Mid-Day: The NASDAQ is DOWN -0.50 (-0.02%) to 3,076.64 while the Dow is UP +4.19 (+0.03%) to 13,107.18.

View the full article

[ImmInst]

RegMed sector, welcome back to volatile markets
Proactive Investors USA & Canada - 1 hour ago

The 6 W's: Who, what, where, when, why and what of it. Starting the month off. Mid-Day: The NASDAQ is DOWN -14.67 (-0.48%) to 3,052.29 while the Dow is DOWN -84.98 (-0.65%) to 13,005.86.

View the full article

[ImmInst]

RegMed sector, sharp market gains
Proactive Investors USA & Canada - 2 hours ago

The 6 W's: Who, what, where, when, why and what of it. After these past days any sector movement is welcomed! Mid-Day: The NASDAQ is UP +63.14 (+2.06%) to 3,132.41 while the Dow is UP +234.81 (+1.80%) to 13,282.29.

View the full article

[ImmInst]

RegMed sector, just when we thought the road was widening
Proactive Investors USA & Canada - 50 minutes ago

3:34 pm by Henry McCusker. The 6 W's: Who, what, where, when, why and what of it: GERN's discontinued program casts a shadow over sector.

View the full article

[ImmInst]

Teva Launches Generic Version of Pfizer's Detrusitol; Geron Discontinues Phase ...
Proactive Investors USA & Canada - 3 hours ago

Teva Launches Generic Version of Pfizer's Detrusitol; Geron Discontinues Phase II Study of Imetelstat. 1:13 pm by Staff and Wire Reports.

View the full article

[ImmInst]

New Legislation Passed to Help Speed Up FDA Review Process
Marketwire (press release) - 1 hour ago

NEW YORK, NY--(Marketwire - Sep 17, 2012) - Despite concerns of a global economic slowdown the Biotech Industry has impressed investors with strong gains in 2012.

View the full article

[ImmInst]

RegMed sector, investors take a breather
Proactive Investors USA & Canada - Sep 17, 2012

The 6 W's: Who, what, where, when, why and what of it. Mid-Day: The NASDAQ is UP +2.50 (+0.08%) to 3,116.81 while the Dow is UP +6.35 (+0.05%) to 13,339.70.

View the full article

[ImmInst]

RegMed sector, Friday is quadruple witching day
Proactive Investors USA & Canada - 2 hours ago

The 6 W's: Who, what, where, when, why and what of it … Today's Viewpoint: RegMed stocks were higher Friday, with the NASDAQ hitting its best level in nearly 12 years.

View the full article

[ImmInst]

RegMed sector, investors are stumbling around beat-up, tone-deaf and sightless
Proactive Investors USA & Canada - 2 hours ago

The 6 W's: Who, what, where, when, why and what of it. Today's Viewpoint: RegMed stocks were chaotic … seemingly dazed or just largely “beat-up” by advancing markets after a couple of “up-beat” economic indicators.

View the full article

[ImmInst]

BioTime Forms BioTime Acquisition Corporation
DailyFinance - 1 hour ago

BioTime Forms BioTime Acquisition Corporation. By BusinessWirevia The Motley Fool. Posted 1:05PM 09/28/12 Posted under: Investing · Share.

BioTime Forms BioTime Acquisition Corp. - NASDAQ
BIOTIME, INC. : BioTime Forms BioTime Acquisition Corporation - 4-traders

View the full article

[ImmInst]

BioTime Forms BioTime Acquisition Corporation
EON: Enhanced Online News (press release) - Sep 29, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, ...

View the full article

[ImmInst]

BIOTIME, INC. : BioTime Forms BioTime Acquisition Corporation
4-traders - Sep 28, 2012

BioTime, Inc. : BioTime Forms BioTime Acquisition Corporation. 09/28/2012 | 12:45pm US/Eastern. Subsidiary will seek to acquire assets and businesses in the stem cell and regenerative medicine fields.

View the full article

[ImmInst]

RegMed sector, Welcome to Q4/12
Proactive Investors USA & Canada - 55 minutes ago

The 6 W's: Who, what, where, when, why and what of it … Today's View: The RegMed sector opened to minutiae moves <some recapturing past pricing> and then loosing the short moves at the mid-day … all this on the first day of Q4.

View the full article

[ImmInst]

BioTime forms new wholly owned subsidiary
News-Medical.net - Sep 29, 2012

BioTime, Inc. (NYSE MKT: BTX), an Alameda-based company engaged in research and development of innovative new products in the field of regenerative medicine utilizing stem cells and related technology, announced today that it has formed a new wholly ...

View the full article

[ImmInst]

Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint ...
SYS-CON Media (press release) - 1 hour ago

NEW YORK, NY -- (Marketwire) -- 10/02/12 -- The Biotechnology Industry has seen increased investor interest in 2012 as it continues to impress with strong gains.

View the full article

[ImmInst]

RegMed sector, investors are looking forward to development results and cash ...
Proactive Investors USA & Canada - 10 minutes ago

The 6 W's: Who, what, where, when, why and what of it … Today's View: The RegMed sector stocks rose …edging higher after a choppy open Wednesday, lifted by a batch of better-than-expected economic reports, but investors remained on edge amid ...

View the full article

[ImmInst]

Mr. Market's Stem Cell Roulette
Seeking Alpha - 3 hours ago

Historically, stem cell stocks were terrible investments that have done nothing but drain investor value through a bunch of share dilutions and other financing efforts from the ambitious companies.

View the full article